1. Home
  2. SMHI vs PRLD Comparison

SMHI vs PRLD Comparison

Compare SMHI & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo SEACOR Marine Holdings Inc.

SMHI

SEACOR Marine Holdings Inc.

HOLD

Current Price

$7.47

Market Cap

207.0M

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$4.93

Market Cap

218.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SMHI
PRLD
Founded
1989
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
207.0M
218.0M
IPO Year
2016
2020

Fundamental Metrics

Financial Performance
Metric
SMHI
PRLD
Price
$7.47
$4.93
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.67
AVG Volume (30 Days)
58.7K
548.8K
Earning Date
04-29-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
62.41
23.21
EPS
N/A
N/A
Revenue
$173,783,000.00
$12,140,000.00
Revenue This Year
$1.21
$320.10
Revenue Next Year
$9.31
$100.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
73.43
52 Week Low
$4.70
$0.75
52 Week High
$8.17
$5.54

Technical Indicators

Market Signals
Indicator
SMHI
PRLD
Relative Strength Index (RSI) 50.31 57.06
Support Level $6.82 $1.09
Resistance Level $7.90 $5.54
Average True Range (ATR) 0.31 0.57
MACD 0.01 -0.02
Stochastic Oscillator 65.26 69.12

Price Performance

Historical Comparison
SMHI
PRLD

About SMHI SEACOR Marine Holdings Inc.

Seacor Marine Holdings Inc provides marine and support transportation services to offshore energy facilities globally. The company operates and manages a diverse fleet of offshore support vessels that (i) deliver cargo and personnel to offshore installations, including offshore wind farms, (ii) assist offshore operations for production and storage facilities, (iii) provide construction, well work-over, offshore wind farm installation and decommissioning support and (iv) carry and launch equipment used underwater in drilling and well installation, maintenance, inspection and repair. Its geographical segment includes the United States (Gulf of Mexico), Africa and Europe, Middle East and Asia, and Latin America, with the majority of revenue deriving from the Africa and Europe segment.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a precision oncology company developing medicines in areas of high unmet need for cancer patients. Its pipeline features selective KAT6A degraders and mutant selective JAK2V617F JH2 inhibitors, new approaches to clinically validated targets with transformative potential for patients. The company is also leveraging its expertise in targeted protein degradation to discover and develop next-generation degrader antibody conjugates (DACs) with novel payloads.

Share on Social Networks: